Target Name: GOT1-DT
NCBI ID: G101927300
Review Report on GOT1-DT Target / Biomarker Content of Review Report on GOT1-DT Target / Biomarker
GOT1-DT
Other Name(s): LOC101927300 variant X1 | GOT1 divergent transcript | Uncharacterized LOC101927300, transcript variant X1

GOT1-DT: A Potential Drug Target or Biomarker for Cancer

GOT1-DT (LOC101927300) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 10 and has been shown to play a role in the regulation of cell growth and differentiation.

GOT1-DT has been shown to be involved in the development and progression of various diseases, including cancer. Studies have shown that high levels of GOT1-DT are associated with an increased risk of cancer, and that inhibiting the activity of the gene has the potential to be a cancer treatment.

One of the key features of GOT1-DT is its role in the regulation of cell growth and differentiation. The gene is known to be involved in the development and maintenance of stem cells, and is thought to play a role in the regulation of cell growth and differentiation. This is important because stem cells are a key part of the development and treatment of many diseases, including cancer.

Another important function of GOT1-DT is its role in the regulation of cell death. The gene is known to be involved in the regulation of cell death, and is thought to play a role in the control of cell life cycle. This is important because cell death is a critical part of the regulation of many diseases, including cancer.

In addition to its role in cell growth and differentiation, GOT1-DT is also known to be involved in the regulation of inflammation. The gene is known to be involved in the regulation of inflammation, and is thought to play a role in the development of many diseases, including cancer.

GOT1-DT is also of interest as a potential biomarker for the diagnosis and prognosis of cancer. Many diseases, including cancer, can be detected at an early stage through the analysis of biomarkers, which are indicators of the presence of certain proteins or genetic abnormalities. Studies have shown that GOT1-DT is a potential biomarker for the diagnosis and prognosis of cancer, and that its levels can be used as a diagnostic marker for many diseases, including cancer.

In conclusion, GOT1-DT is a gene that has been shown to play a role in the regulation of cell growth and differentiation, and is of interest as a potential drug target or biomarker for the treatment of various diseases, including cancer. Further research is needed to fully understand the role of GOT1-DT in the regulation of cell growth and differentiation, and to determine its potential as a drug target or biomarker.

Protein Name: GOT1 Divergent Transcript

The "GOT1-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOT1-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GOT1L1 | GOT2 | GOT2P1 | GP1BA | GP1BB | GP2 | GP5 | GP6 | GP9 | GPA33 | GPAA1 | GPALPP1 | GPAM | GPANK1 | GPAT2 | GPAT3 | GPAT4 | GPATCH1 | GPATCH11 | GPATCH2 | GPATCH2L | GPATCH3 | GPATCH4 | GPATCH8 | GPBAR1 | GPBP1 | GPBP1L1 | GPC1 | GPC1-AS1 | GPC2 | GPC3 | GPC4 | GPC5 | GPC5-AS1 | GPC5-AS2 | GPC6 | GPC6-AS1 | GPC6-AS2 | GPCPD1 | GPD1 | GPD1L | GPD2 | GPER1 | GPHA2 | GPHB5 | GPHN | GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19